Is Adverum Biotechnologies Inc (NASDAQ: ADVM) Still A Buy After A -11.58% Weekly Drop?
During the last session, Adverum Biotechnologies Inc (NASDAQ:ADVM)’s traded shares were 0.34 million, with the beta value of the company hitting 0.70. At the end
During the last session, Adverum Biotechnologies Inc (NASDAQ:ADVM)’s traded shares were 0.34 million, with the beta value of the company hitting 0.70. At the end
During the last session, Armlogi Holding Corp (NASDAQ:BTOC)’s traded shares were 78919.0, with the beta value of the company hitting 2.16. At the end of
During the last session, Fangdd Network Group Ltd (NASDAQ:DUO)’s traded shares were 69466.0, with the beta value of the company hitting 2.66. At the end
During the last session, Nektar Therapeutics (NASDAQ:NKTR)’s traded shares were 0.45 million, with the beta value of the company hitting 0.56. At the end of
During the last session, Altisource Portfolio Solutions S.A (NASDAQ:ASPS)’s traded shares were 73690.0, with the beta value of the company hitting 0.02. At the end
During the last session, BuzzFeed Inc (NASDAQ:BZFD)’s traded shares were 0.15 million, with the beta value of the company hitting 3.55. At the end of
During the last session, Movano Inc (NASDAQ:MOVE)’s traded shares were 0.19 million, with the beta value of the company hitting 0.79. At the end of
During the last session, Lands’ End, Inc (NASDAQ:LE)’s traded shares were 0.41 million, with the beta value of the company hitting 2.44. At the end
During the last session, System1 Inc (NYSE:SST)’s traded shares were 0.14 million, with the beta value of the company hitting 1.21. At the end of
During the last session, NanoViricides Inc (AMEX:NNVC)’s traded shares were 0.12 million, with the beta value of the company hitting 0.91. The 52-week high for
© 2024, Powered by Smart TechOne